Healthy Clinical Trial
— FGF21-APAOfficial title:
Effect of Protein and Retinol on Alcohol-induced FGF21
The aims of this study are two-fold. First to investigate the influence of protein on the FGF21 response induced by alcohol, and second to investigate the influence of retinol on FGF21 concentrations and the FGF21 response induced by alcohol. Exploratory, and in order to investigate mechanisms behind the potential influence on alcohol-induced FGF21 response from protein or retinol intake, plasma glucose, insulin, glucagon, ethanol, acetaldehyde, acetate, retinol, retinoic acid, as well as subjective rating of appetite, will be measured.
Status | Recruiting |
Enrollment | 30 |
Est. completion date | March 31, 2024 |
Est. primary completion date | March 31, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 50 Years |
Eligibility | Inclusion Criteria: - Informed consent - Healthy men and women - Age between 18 and 50 years - Body mass index (BMI) between 20 and 27 kg/m2 Exclusion Criteria: - Chronic diseases or significant health problems that are disruptive for participation in the study (as judged by the principal investigator/clinical responsible) - Use, currently or within the previous 3 months, of medication that has the potential of affecting any of the blood parameters assessed in the study (as judged by the investigators) - Blood donation within the last 3 months or during the study period - Regular smoking or other nicotine use (electronic cigarettes, gum, snus, etc.) or nicotine cessation within the past 3 months. - Currently dieting or having lost/gained a significant amount of weight (±3 kg) in the previous 3 months - Women who are pregnant, breast-feeding or have the intention of becoming pregnant during the study period - Food allergies or food intolerance relevant for the study (judged by the investigators) - Substance abuse (alcohol and/or drugs) within the last 12 months - Average weekly alcohol intake above the recommendations from the Danish Health and Medicines Authority (10 standard units per week) - Taking dietary supplements containing vitamin A during the past 3 months - Simultaneous participation in other clinical studies that can interfere with the current study - Inability, physically or mentally, to comply with the procedures required by the study protocol |
Country | Name | City | State |
---|---|---|---|
Denmark | Departmen of Nutrition, Exercise and Sports | Copenhagen |
Lead Sponsor | Collaborator |
---|---|
University of Copenhagen |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Plasma FGF21 response after consumption of alcohol+protein vs alcohol | Time*drink interaction and iAUC | Outcomes are measured at time 0, 30, 60, 120, 180, and 240 minutes after test drinks. | |
Primary | Plasma FGF21 response after consumption of alcohol+retinol vs alcohol vs retinol | Time*drink interaction and iAUC | Outcomes are measured at time 0, 30, 60, 120, 180, and 240 minutes after test drinks. | |
Secondary | Plasma glucose, insulin, glucagon, ethanol, acetaldehyde, acetate, retinol, and retinoic acid after consumption of alcohol+protein vs alcohol+retinol vs alcohol vs retinol. | Time*drink interaction and iAUC | Outcomes are measured at time 0, 30, 60, 120, 180, and 240 minutes after test drinks. | |
Secondary | Subjective appetite ratings after consumption of alcohol+protein vs alcohol+retinol vs alcohol vs retinol. | Time*drink interaction and iAUC | Outcomes are measured at time 0, 30, 60, 120, 180, and 240 minutes after test drinks. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |